SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Sepracor-Looks very promising -- Ignore unavailable to you. Want to Upgrade?

To: Ed Ajootian who wrote (1215)9/30/1998 8:39:00 AM
From: Frank Haims  Read Replies (1) | Respond to of 10280
 
Another Sepracor Riddle

"What did June Allison say about the Oxybutydnin (sp) trials?"

Answer tomorrow.
Frank



To: Ed Ajootian who wrote (1215)9/30/1998 3:42:00 PM
From: Bob Swift  Read Replies (1) | Respond to of 10280
 
Lehman's target of 62 at year end seems to be a little low. Last night I put in an order for 2500 at 61.5 since on its way down people always over do it. A look at the intraday chart showed that there was a free fall from 64.5 to 61.5 with nothing in between. Sometimes people just panic, I should have put in an order of $2 instead of $61.5. SEPR has now attracted momentum traders like honey attracts flies.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News